Loading
Total declarations
Companies
▲ Purchases (152 ops.)
▼ Sales (47 ops.)
Latest filing published 04 Jan 2012 for Seagen Inc., €239k.
Insider track record
Disclosed buys
152
Disclosed sells
47
Signal history
No signal scores available.
Closed purchases
Market purchases
152
Positive at T+90
48%
Median T+90
-2.9%
Based on 48 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +484.9%Entry US$2.05 · Close at T+365 US$11.99
- +368.6%Entry US$2.42 · Close at T+365 US$11.34
- +148.7%Entry US$3.51 · Close at T+365 US$8.73
- +527.7%Entry US$1.30 · Close at T+365 US$8.16
- -41.7%Entry US$9.59 · Close at T+365 US$5.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Baker / Tisch Capital (GP), LLC: trading record in brief
Baker / Tisch Capital (GP), LLC is a declared insider at 11 companies; the most frequent names are Incyte Corp, Viropharma Inc and Allos Therapeutics Inc. In total, 215 filings cover trades dated from 9 January 2006 to 30 December 2011.
On the open market, the record shows 152 purchases worth €1.8M and 47 sales worth €1.8M. The net balance comes to €70k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants.
A typical purchase (the median) is worth €1,891. Ninety days after publication, 48 purchases show a median change of -2.9%, with the price up in 48% of them. They describe history only and say nothing certain about the share price ahead.
On 4 January 2012 came the latest disclosure, a share grant for €239k in Seagen Inc. The last insider purchase was made public on 26 May 2009, 6,359 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Baker / Tisch Capital (GP), LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations203 total
49,563 shares@ US$6.25Common StockSEC:0001144204-12-000544:0
12,679 shares@ US$4.25Common StockSEC:0001144204-12-000278:0
8,821 sharesCommon StockSEC:0001144204-11-061501:0
56,954 sharesCommon StockSEC:0001144204-11-061501:1
53,754 sharesCommon StockSEC:0001144204-11-061501:2
55,187 sharesCommon StockSEC:0001144204-11-061501:3
3,243 shares@ US$18.0295Common StockSEC:0001144204-11-043706:0
4,902 shares@ US$18.0389Common StockSEC:0001144204-11-043706:1
507 shares@ US$17.248Common StockSEC:0001144204-11-043706:2
83,119 shares0Common StockSEC:0001144204-11-029226:0
37 shares@ US$1.277Common StockSEC:0001144204-10-056522:0
91 shares@ US$1.30Common StockSEC:0001144204-10-056522:1
142 shares@ US$1.1884Common StockSEC:0001144204-10-056522:2
60 shares@ US$1.183Common StockSEC:0001144204-10-056522:3
12,974 shares@ US$14.943Common StockSEC:0001144204-10-050697:0
4,829 shares@ US$14.7118Common StockSEC:0001144204-10-050697:1
3,820 shares@ US$14.8608Common StockSEC:0001144204-10-050697:2
2,629 shares@ US$14.0873Common StockSEC:0001144204-10-042899:0
4,041 shares@ US$14.0813Common StockSEC:0001144204-10-042899:1
638 shares@ US$13.9999Common StockSEC:0001144204-10-042899:2
1,239 shares@ US$13.998Common StockSEC:0001144204-10-042899:3
50,294 shares@ US$6.75Common StockSEC:0001144204-09-050448:0
1,651 shares@ US$4.4535Common StockSEC:0001144204-09-030385:0
2,975 shares@ US$4.5041Common StockSEC:0001144204-09-030385:1
402 shares@ US$4.3013Common StockSEC:0001144204-09-030385:2
25 of 203 declarations
